Fab Region: Contains variable domains (VH and VL) that enable antigen recognition, critical for binding the SPBC16G5.07c protein .
Fc Region: Mediates immune effector functions (e.g., phagocytosis), though this is less relevant in non-immunological research applications .
While direct structural data for SPBC16G5.07c is limited, fission yeast proteins often participate in:
Chromosome segregation
DNA repair mechanisms
Cytokinesis regulation
Functional Genomics: Studying gene knockout or overexpression phenotypes in S. pombe.
Protein Localization: Mapping subcellular distribution via immunofluorescence .
No peer-reviewed studies specifically referencing SPBC16G5.07c Antibody were identified in available literature ( ).
Commercial documentation lacks detailed validation data (e.g., epitope mapping, cross-reactivity assays) .
The Structural Antibody Database (SAbDab) catalogs 1,624 antibody structures but does not include SPBC16G5.07c Antibody, highlighting its niche research focus . General antibody trends from SAbDab:
| Feature | Typical Antibody | SPBC16G5.07c Antibody |
|---|---|---|
| Antigen Type | Pathogen-derived or human proteins | Fission yeast protein |
| Structural Resolution | High (X-ray crystallography) | Undetermined (likely ELISA/Western) |
| Therapeutic Relevance | Common | None |
KEGG: spo:SPBC16G5.07c
STRING: 4896.SPBC16G5.07c.1
SPBC16G5.07c is a systematic identifier for a gene/protein in Schizosaccharomyces pombe (fission yeast). Similar to other SPBC-prefixed identifiers in S. pombe, it follows the standardized nomenclature system for this model organism. Based on genomic organization, SPBC16G5.07c is located near SPBC16G5.06, which is annotated as a "sequence orphan" protein-coding gene . In S. pombe, several proteins with SPBC identifiers have been characterized in various cellular processes, including involvement in chromatin remodeling complexes and nuclear functions.
Antibodies against S. pombe proteins are used in several key techniques:
Custom antibodies are essential for studying proteins like SPBC16G5.07c because:
Many S. pombe proteins lack commercially available antibodies, particularly for sequence orphans and uncharacterized proteins .
These proteins may have unique epitopes requiring specific antibody development strategies.
Research on novel proteins requires validated reagents to establish their function in cellular processes.
For comprehensive characterization of protein complexes, antibodies against each component are needed for co-immunoprecipitation and other interaction studies .
For developing antibodies against S. pombe proteins, researchers should consider these methodological approaches:
Epitope Selection: Analyze the protein sequence using bioinformatics tools to identify antigenic regions that are surface-exposed and unique.
Expression Strategy:
Recombinant expression of full-length protein or protein fragments
Synthetic peptide conjugation to carrier proteins
For sequence orphans, structural prediction may help identify optimal epitopes
Host Selection:
Rabbits for polyclonal antibodies with broader epitope recognition
Mice for monoclonal antibody development with higher specificity
Affinity Purification: Implement antigen-specific purification to minimize cross-reactivity with other yeast proteins .
Antibody validation is critical and should include multiple approaches:
Western blot analysis comparing:
Wild-type vs. deletion mutant strains
Untagged vs. epitope-tagged versions of the protein
Different cellular fractions to confirm predicted localization
Immunoprecipitation followed by:
Mass spectrometry to confirm target identity
Testing for expected interaction partners
Cross-reactivity assessment:
Developing antibodies against orphan proteins presents several challenges:
Limited structural information: Without known homologs, predicting antigenic regions is difficult.
Unknown expression levels: Low abundance proteins may require more sensitive detection methods.
Post-translational modifications: Unknown modifications may affect epitope accessibility.
Validation complexity: Without characterized function, validation relies heavily on genetic approaches (tagging, deletion) .
Cross-reactivity risk: Higher potential for non-specific binding in the absence of comparative sequence data.
Computational approaches significantly enhance antibody design through:
In silico antibody design protocols like those outlined in IsAb:
Utilize RosettaAntibody to address the absence of 3D structures
Apply RosettaRelax to minimize energy of protein structures
Perform two-step docking (global and local) to address binding information gaps
Use alanine scanning to predict antibody hotspots
Implement computational affinity maturation to improve properties
Machine learning applications:
Structural databases utilization:
For successful ChIP experiments with S. pombe proteins, researchers should consider:
Chromatin preparation:
Antibody quality factors:
Controls and normalization:
Data analysis:
Histone modifications significantly impact antibody-based detection of chromatin proteins:
Epitope masking: Modifications can physically block antibody access to target proteins.
Chromatin compaction effects:
Modification-dependent interactions:
Cross-reactivity considerations:
Optimization strategies for immunoprecipitation include:
Lysis buffer optimization:
Antibody coupling approaches:
Direct coupling to beads for cleaner results
Pre-clearing lysates to reduce non-specific binding
Testing both protein A and protein G matrices
Protocol modifications for specific applications:
Elution strategies:
Cellular state significantly impacts antibody-based detection:
Cell cycle-dependent changes:
Stress response effects:
Quiescent state considerations:
Methodological adaptations:
High-throughput sequencing technologies enhance antibody-based studies through:
ChIP-seq applications:
Single-cell applications:
Computational integration:
Method innovations:
Recent structural biology advances include:
Cryo-EM applications:
Higher resolution structures of antibody-antigen complexes
Visualization of conformational epitopes
Analysis of larger complexes than possible with crystallography
AlphaFold2 integration:
Molecular dynamics simulations:
Structural databases: